期刊文献+

腹腔镜下根治性手术治疗肾癌患者对血清Ang、VEGF及T细胞亚群的影响

Influence of laparoscopic radical operation on serum Ang, VEGF and T cell subsets in patients with renal carcinoma
下载PDF
导出
摘要 目的分析腹腔镜下根治性手术治疗肾癌患者对血清血管生成素(Ang)、血管内皮生长因子(VEGF)及T细胞亚群的影响。方法选取120例肾癌患者随机分为对照组(60例,给予开式手术)与研究组(60例,给予腹腔镜手术)。对比术前、术后3d两组血清Ang、VEGF、T细胞亚群水平等指标变化情况。结果术后3 d,研究组Ang-1、Ang-2、ATIR、VEGF-A、VEGF-C、VEGF-D显著低于对照组(P<0.05);两组CD3^+、CD4^+、CD4^+/CD8^+均显著降低,但研究组显著高于对照组(P<0.05)。结论腹腔镜下根治性手术对肾癌患者血清Ang、VEGF及T细胞亚群的影响更小。 Objective To analyze the influence of laparoscopic radical operation on serum angiogenin (Ang), vascular endothelial growth factor (VEGF) and T lymphocyte subsets in patients with renal carcinoma. Methods' A total of 120 patients with renal cancer were randomly divided into control group (60 cases, given open surgery) and study group (60 cases, given laparoseopie radical surgery). The levels of serum Ang, VEGF and T cell subsets in the two groups were compared before operation and at 3 d after operation. Results' The levels of Ang-1, Ang-2, ATIR and VEGF-A, VEGF-C and VEGF-D at postoperative 3 d in the study group were significantly lower than those in the control group (P〈0.05). The levels of CD3+, CD4+ and CD4+/CD8+ in the two groups decreased significantly after operation, and those of the study group were significantly higher than the control group (P〈0.05). Conclusion Laparoseopie radical surgery has less effect on serum Ang, VEGF and T cell subsets in patients with renal carcinoma.
作者 张建斌 贺艳峰 ZHANG Jian-bin;HEN Yan-feng(No.215 Hospital of Shawtxi Nuclear Industry, Xianyang 712000, China)
机构地区 陕西核工业
出处 《临床医学研究与实践》 2018年第13期59-60,89,共3页 Clinical Research and Practice
关键词 肾癌 腹腔镜下根治性手术 血管生成素 T细胞亚群 renal carcinoma laparoseopie radical surgery angiogenin T cell subsets
  • 相关文献

参考文献9

二级参考文献92

  • 1潘寿华,汪朔,徐刚,吴刚峰,阎家峻.后腹腔入路与经腹入路腹腔镜下肾癌根治术的临床比较[J].中国内镜杂志,2008,14(10):1076-1078. 被引量:6
  • 2郭旭东,王翰博,任祥斌,李关彬,金讯波,蒋绍博.非阻断肾动脉腹腔镜肾部分切除术治疗T_(1a)期肾癌的临床研究[J].泌尿外科杂志(电子版),2014,6(2):11-14. 被引量:7
  • 3Hutson TE. Renal cell carcinoma: dial osis and treatment, 1994- 2003[J]. Proc Bayl Univ Med Cent, 2005, 18(4) : 337 -3340.
  • 4Ljungberg B, Campbell SC, Cho HY, et al. The epidemiology of renal cell carcinoma [J]. Eur Urol, 2011, 60(4) : 29 -36.
  • 5O'Reilly V, Zeng SG, Bricard G, et al. Distinct and overlapping effector functions of expanded human CD4 + , CD8ct + and CD4- CD8 alpha in variant natural killer T cells[J]. PLoS One, 2011, 6(12) : e28648.
  • 6Rodriguez Carlin A, Vidal Mora I, Arellano L, et al. Renal cell carcinoma of the collecting ducts of bellini with retmperitoneal recurrence by another histological subtype of renal rumor [ J ]. Arch Esp Urol, 2013, 66(6) : 597 -601.
  • 7Kryczek I, Wei S, Zou L, et al. Cutting edge: Thl7 and regulatory T cell dynamics and the regulation by IL-2 in the tumor [J]. Immunology, 2007, 178(11) : 6730 -6733.
  • 8Wilke CM, Kryczek I, Wei S, et al. Thl7 Cells in cancer: help or hindrance[J]. Carcinogenesis, 2011,32(5): 643 -649.
  • 9Martins SF, Gareia EA, Luz MA, et al. Clinicopathological cor- relation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer [ J ]. Cancer Genomics Proteomics, 2013,10 (2) :55.
  • 10Zhang JP, Yan J, Xu J, et al. Increased intratumoral IL-17-pro- ducing cells correlate with poor survival in hepatocellular carcino- ma patients [ J ]. Hepatology,2009, 50 (5) : 980 - 989.

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部